ISSN: 2640-799X
Rheumatica Acta: Open Access
Case Report       Open Access      Peer-Reviewed

Idiopathic Intracranial Hypertension: Neuropsychiatric Systemic Lupus Erythematosus or Gonadotropin- releasing hormone agonist side effect?

Ong Ping Seung*, Ng Yong Muh and Khor Chiew Gek

Department of Rheumatology, Hospital Raja Permaisuri Bainun, Malaysia
*Corresponding author: Ong Ping Seung, Hospital Raja Permaisuri Bainun, Jalan Raja Ashman Shah (Jalan Hospital), 30450 Ipoh, Perak, Malaysia, Tel: +60135212100; + 6052422100; Fax: +6052422100; E-mail: ongps@hotmail.com
Received: 17 June, 2017 | Accepted: 03 July, 2017 | Published: 04 July, 2017
Keywords: Gonadotropin-releasing hormone analogues; Neuropsychiatric; Systemic lupus erythematosus; Idiopathic intracranial hypertension; Side effect

Cite this as

Seung OP, Muh NY, Gek KC (2017) Idiopathic Intracranial Hypertension: Neuropsychiatric Systemic Lupus Erythematosus or Gonadotropin- releasing hormone agonist side effect? Rheumatica Acta: Open Access 1(1): 023-024. DOI: 10.17352/raoa.000006

A 31-year-old systemic lupus erythematotus (SLE) patient presented with headache and blurring of vision. Prior to this, she received 2 doses of monthly triptorelin for endometriosis. On examination, she had bilateral sixth nerve paresis. The diagnosis of idiopthic intracranial hypertension (IIH) was confirmed by an increased intracranial pressure and normal neuroimaging studies of the brain. After releasing the cerebrospinal pressure and cessation of triptorelin, the clinical symptoms resolved without further treatment. It is important to identify the drugs causing IIH rather than attribute to neuropsychiatric SLE to prevent unnecessary treatment.

Introduction

Idiopathic intracranial hypertension (IIH) is one of the rare presentation of neuropsychiatric systemic lupus erythematosus (SLE) and may present with unremitting headache [1]. IIH also known as pseudotumor cerebri or benign intracranial hypertension, can be presentations of neuropsychiatric SLE or an adverse events of drugs such as Gonadotropin-releasing hormone (GnRH) analogues.

Here, we report a SLE patient who developed IIH after treated with triptorelin, a synthetic GnRH analogue for endometriosis.

Case Report

A 31 year old lady presented with headache and blurring of vision for 3 days. She had double visions on lateral view of both eyes. There was no fever, joint pain, rashes, oral ulcers or dyspnoea. Two years earlier, she was diagnosed to have endometriosis after suffering from dysmenorrhea for more than 5 years. After failure of hormone pills, she was started on monthly triptorelin and had her second injection 2 weeks before this presentations.

Upon examination, she was not obese with blood pressure 110/75 mm Hg and temperature of 37 OC. Extraocular movements demonstrated bilateral sixth nerve paresis and fundoscopy didn’t reveal papilledema. The other physical examinations were otherwise normal.

Laboratory examinations on admission were unremarkable. MRI (Magnetic resonance Imaging) brain done showed no intracranial mass or ventricular dilatation. The MR venogram disclosed no evidence of dural venous thrombosis.

Lumbar puncture was urgently performed which showed an opening pressure of 25 cm H2O with patient lying on the side. Cerebrospinal fluid (CSF) was drained and analysis was normal. The closing pressure was 19 cm H2O.Based on these findings, the patient was diagnosed with IIH and triptorelin was discontinued. One day after the lumbar puncture, her headache improved tremendously without any further treatment. A week later, she was seen in outpatient clinic, both her diplopia and headache resolved completely.

Discussion

Diagnosis of IIH is based on the modified Dandy criteria [2]. This patient fulfilled all these criteria which include symptoms and signs of intracranial pressure, no neurological examination except VI nerve palsy, normal neurodiagnostic studies, normal CSF analysis, increased CSF pressure and no abnormality in consciousness level.

IIH was first reported in SLE patient by Bettman el al in 1968 [3]. Since then it had been recognized as a syndrome of neuropsychiatric SLE and one of the causes of headache in SLE. The pathogenetic mechanism is not clear. Probable mechanisms include immune-mediated injury within the archnoid villi leading to decrease CSF absorption and/ or thrombotic obliteration of cerebral arteriolar and venous systems due to a hypercoagulable state [4-6]. IIH is an uncommon presentation of neuropsychiatric SLE but with favourable outcome [7]. High dose oral corticosteroids remains the main stay for treatment of IIH in patients with SLE while intravenous mannitol or acetazolamide can be used to reduce intracranial tension [8].

GnRH analogues was reported rarely to cause IIH in adult patient’s [9,10]. This patient was given 2 doses of monthly triptorelin 3.75mg for endometriosis before she developed headache and diplopia. In view of this, we attributed the cause for IIH was GnRH analogues rather than presentations of neuropsychiatric SLE. The treatment for both is rather different. For GnRH analogues induced IIH, omitting the culprit drugs and normalizing the CSF pressure, clinical symptoms will improve as clearly seen in this case [11]. To our knowledge, this is the first GnRH analogues induced IIH in adult SLE patients reported.

Conclusion

In SLE patients, it is important to identify the potential drugs that might cause IIH rather than attribute it as neuropsychiatric SLE presentations as this would prevent patient from getting unnecessary treatment such as high dose steroids.

  1. Hahn BH (2012) Systemic lupus erythematosus in Harrisons principles of internal medicine 18 th edn. New York Graw Hill: 2724-2735. Link: https://goo.gl/6fqJQn
  2. Wall M (1991) Idiopathic Intracranial hypertension. Neurol Clin 9: 73-95.
  3. Bettman JW Jr, Daroff RB, Sanders MD (1968) Papillodema and asymptomatic intracranial hypertension in systemic lupus erythematosus. A fluroscein angiographic study of resolving papilloedema. Arch Ohthalmol 80:189-193. Link: https://goo.gl/LBJQae
  4. Semanur Kuyucu, Atila Argin, Necdet Kuyucu, Ozen S (2007) Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association. Turk J Pediatr 49: 98-101. Link: https://goo.gl/uSx6oa
  5. Horoshovski D, Amital H, Katz M, Shoenfeld Y (1995) Pseudotumor cerebri in SLE. Clin Rheumatol 14: 708-710 Link: https://goo.gl/RwRi1R
  6. Li Ek, Ho PCP (1989) Pseudotumor cerebri in systemic lupsu erythematosus. J Rheumatol 16:113-116 Link: https://goo.gl/NzHdBN
  7. Yoo Wh, Park JH, Kin HK, Park TS, Baek HS (2001) Recurrent pseudotumor cerebri in systemic lupus erythematosus: a case report. J Korean Medi Sci16: 805-808 Link: https://goo.gl/MqP6Tc
  8. Hershko AY, Berkun Y, Mevorach D, Rubinow A, Naparstek Y (2008) Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience. Semin Arthritis Rheum 38: 110-115 Link: https://goo.gl/XJ1inm
  9. Bhatt UK, Haq I, Avadhanam VS, Bibby K (2012) A 43-yar-old woman on triptorelin presenting with pseudotumor cerebri : a case report. J Med Case Rep 6: 122 Link: https://goo.gl/rNr3HJ
  10. Alexander J, Levi L (2013) Intracranial hypertension in a patient preparing for gestational surrogacy with leuprolide acetate and estrogen.J Neuroophthalamol 33: 310-311 Link: https://goo.gl/zbJw23
  11. Ulku Gul, Ayse KAcar Bayram, Mustafa Kendirci, et al. (2016) Pseudotmour Cerebri Presentation in a Child under Gonadotropin -Releasing homrone Agost Treatment. J Clin Res Pediatr Endocrinol 8: 365-367.
© 2017 Seung OP, et al. This is an open-access Case Report distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.